Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001213900-17-004886
Filing Date
2017-05-10
Accepted
2017-05-10 17:01:04
Documents
1
Period of Report
2017-03-31
Effectiveness Date
2017-05-10

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING extf10q0317_actinium.htm NT 10-Q 32971
  Complete submission text file 0001213900-17-004886.txt   34104
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 17831344
SIC: 2834 Pharmaceutical Preparations